Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 1372-1377, March 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devalaraja, M. N.
Right arrow Articles by Richmond, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devalaraja, M. N.
Right arrow Articles by Richmond, A.
[Cancer Research 59, 1372-1377, March 15, 1999]
© 1999 American Association for Cancer Research


Tumor Biology

Elevated Constitutive I{kappa}B Kinase Activity and I{kappa}B-{alpha} Phosphorylation in Hs294T Melanoma Cells Lead to Increased Basal MGSA/GRO-{alpha} Transcription1

Madhav N. Devalaraja, Ding Zhi Wang, Dean W. Ballard and Ann Richmond2

Departments of Cell Biology [M. N. D., D. Z. W., A. R.], Microbiology and Immunology [D. W. B.], and Medicine, Division of Dermatology, [A. R.], Vanderbilt University School of Medicine; Veterans Affairs Medical Center [D. Z. W., A. R.]; and Howard Hughes Medical Institute [D. W. B.], Nashville, Tennessee 37212-2637

ABSTRACT

The basal transcription of the CXC chemokine, melanocyte growth stimulatory activity (MGSA)/growth-regulated protein (GRO)-{alpha}, is up-regulated in Hs294T melanoma cells compared with the normal retinal pigment epithelial (RPE) cells. Previous studies characterized a cytokine-inducible, functional nuclear factor (NF) -{kappa}B consensus element in the immediate 5' regulatory region of the MGSA/GRO-{alpha} gene at -78 bp. Although the cytokine-inducible mechanisms for transcription of this gene are fairly well delineated, the mechanisms involved in its basal up-regulation of transcription in Hs294T melanoma cells are poorly understood. Recently, we demonstrated an increased rate of I{kappa}B-{alpha} degradation in Hs294T cells, which leads to an increased nuclear localization of NF-{kappa}B (R. L. Shattuck-Brandt and A. Richmond. Cancer Res., 57: 3032–3039, 1997). Here we demonstrate that Hs294T melanoma cells have elevated basal I{kappa}B kinase (IKK) activity relative to RPE cells, causing an increased constitutive I{kappa}B-{alpha} phosphorylation and degradation. We also show here that the resultant elevated nuclear NF-{kappa}B (p50/p65) in these cells is responsible for the increased basal transcription of MGSA/GRO-{alpha}. Pretreatment of Hs294T or RPE cells with proteasome inhibitors MG115 or MG132 captures the slower migrating, constitutively phosphorylated form of I{kappa}B-{alpha} in Hs294T melanoma cells, but not in RPE cells. In addition, a phospho-specific antibody that specifically recognizes the inhibitory form of I{kappa}B that is phosphorylated at Ser-32 reacted with I{kappa}B-{alpha} in Hs294T cell, but not in unstimulated RPE cells. Although the basal level of protein expression of IKK-{alpha} or IKK-ß are the same in both Hs294T and RPE cells, immunoprecipitation with IKK-{alpha} antibody combined with activity assay reveal a constitutively active IKK complex in Hs294T melanoma cells. Cotransfection of a 350-bp MGSA/GRO-{alpha} promoter-luciferase reporter construct with either the dominant negative IKK-{alpha} or the repressors of NF-{kappa}B, the I{kappa}B-{alpha} wild type or mutants lacking the inducible phosphorylation sites, demonstrates that the increased basal MGSA/GRO-{alpha} transcription in the Hs294T cells is due to the enhanced nuclear activation of NF-{kappa}B.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
G. Sethi, B. Sung, and B. B. Aggarwal
Nuclear Factor-{kappa}B Activation: From Bench to Bedside
Experimental Biology and Medicine, January 1, 2008; 233(1): 21 - 31.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D.-S. Son and K. F. Roby
Interleukin-1{alpha}-Induced Chemokines in Mouse Granulosa Cells: Impact on Keratinocyte Chemoattractant Chemokine, a CXC Subfamily
Mol. Endocrinol., November 1, 2006; 20(11): 2999 - 3013.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Rangaswami, A. Bulbule, and G. C. Kundu
Nuclear Factor-inducing Kinase Plays a Crucial Role in Osteopontin-induced MAPK/I{kappa}B{alpha} Kinase-dependent Nuclear Factor {kappa}B-mediated Promatrix Metalloproteinase-9 Activation
J. Biol. Chem., September 10, 2004; 279(37): 38921 - 38935.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. D. Sue, J. A. Belperio, M. D. Burdick, L. A. Murray, Y. Y. Xue, M. C. Dy, J. J. Kwon, M. P. Keane, and R. M. Strieter
CXCR2 Is Critical to Hyperoxia-Induced Lung Injury
J. Immunol., March 15, 2004; 172(6): 3860 - 3868.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Bian, A. W. Opipari Jr., A. B. Ratanaproeksa, A. E. Boitano, P. C. Lucas, and V. P. Castle
Constitutively Active NFkappa B Is Required for the Survival of S-type Neuroblastoma
J. Biol. Chem., October 25, 2002; 277(44): 42144 - 42150.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
O. Prakash, Z.-Y. Tang, X. Peng, R. Coleman, J. Gill, G. Farr, and F. Samaniego
Tumorigenesis and Aberrant Signaling in Transgenic Mice Expressing the Human Herpesvirus-8 K1 Gene
J Natl Cancer Inst, June 19, 2002; 94(12): 926 - 935.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Dhawan and A. Richmond
A Novel NF-kappa B-inducing Kinase-MAPK Signaling Pathway Up-regulates NF-kappa B Activity in Melanoma Cells
J. Biol. Chem., March 1, 2002; 277(10): 7920 - 7928.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. V. Gasparian, Y. J. Yao, D. Kowalczyk, L. A. Lyakh, A. Karseladze, T. J. Slaga, and I. V. Budunova
The role of IKK in constitutive activation of NF-{kappa}B transcription factor in prostate carcinoma cells
J. Cell Sci., January 1, 2002; 115(1): 141 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. D. Ye
Regulation of nuclear factor {kappa}B activation by G-protein-coupled receptors
J. Leukoc. Biol., December 1, 2001; 70(6): 839 - 848.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. W. Shepard, M. Yang, P. Xie, D. D. Browning, T. Voyno-Yasenetskaya, T. Kozasa, and R. D. Ye
Constitutive Activation of NF-kappa B and Secretion of Interleukin-8 Induced by the G Protein-coupled Receptor of Kaposi's Sarcoma-associated Herpesvirus Involve Galpha 13 and RhoA
J. Biol. Chem., November 30, 2001; 276(49): 45979 - 45987.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Yang, J. Luan, Y. Yu, C. Li, R. A. DePinho, L. Chin, and A. Richmond
Induction of Melanoma in Murine Macrophage Inflammatory Protein 2 Transgenic Mice Heterozygous for Inhibitor of Kinase/Alternate Reading Frame
Cancer Res., November 1, 2001; 61(22): 8150 - 8157.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. L. Guzman, S. J. Neering, D. Upchurch, B. Grimes, D. S. Howard, D. A. Rizzieri, S. M. Luger, and C. T. Jordan
Nuclear factor-{kappa}B is constitutively activated in primitive human acute myelogenous leukemia cells
Blood, October 15, 2001; 98(8): 2301 - 2307.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Chen, V. Castranova, and X. Shi
New Insights into the Role of Nuclear Factor-{kappa}B in Cell Growth Regulation
Am. J. Pathol., August 1, 2001; 159(2): 387 - 397.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
J. Yang and A. Richmond
Constitutive I{{kappa}}B Kinase Activity Correlates with Nuclear Factor-{{kappa}}B Activation in Human Melanoma Cells
Cancer Res., June 1, 2001; 61(12): 4901 - 4909.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Romieu-Mourez, E. Landesman-Bollag, D. C. Seldin, A. M. Traish, F. Mercurio, and G. E. Sonenshein
Roles of IKK Kinases and Protein Kinase CK2 in Activation of Nuclear Factor-{{kappa}}B in Breast Cancer
Cancer Res., May 1, 2001; 61(9): 3810 - 3818.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. M. Dikov, T. Oyama, P. Cheng, T. Takahashi, K. Takahashi, T. Sepetavec, B. Edwards, Y. Adachi, S. Nadaf, T. Daniel, et al.
Vascular Endothelial Growth Factor Effects on Nuclear Factor-{{kappa}}B Activation in Hematopoietic Progenitor Cells
Cancer Res., March 1, 2001; 61(5): 2015 - 2021.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. S. Brar, T. P. Kennedy, A. R. Whorton, A. B. Sturrock, T. P. Huecksteadt, A. J. Ghio, and J. R. Hoidal
Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-{kappa}B in malignant melanoma cells
Am J Physiol Cell Physiol, March 1, 2001; 280(3): C659 - C676.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. H. Li, K. M. Murphy, K. T. Palka, R. M. Surabhi, and R. B. Gaynor
The Human T-cell Leukemia Virus Type-1 Tax Protein Regulates the Activity of the Ikappa B Kinase Complex
J. Biol. Chem., November 26, 1999; 274(48): 34417 - 34424.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. A. Soldatenkov, A. Dritschilo, Z.'e. Ronai, and S. Y. Fuchs
Inhibition of Homologue of Slimb (HOS) Function Sensitizes Human Melanoma Cells for Apoptosis
Cancer Res., October 1, 1999; 59(20): 5085 - 5088.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Nirodi, S. NagDas, S. P. Gygi, G. Olson, R. Aebersold, and A. Richmond
A Role for Poly(ADP-ribose) Polymerase in the Transcriptional Regulation of the Melanoma Growth Stimulatory Activity (CXCL1) Gene Expression
J. Biol. Chem., March 16, 2001; 276(12): 9366 - 9374.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Nirodi, J. Hart, P. Dhawan, N.-s. Moon, A. Nepveu, and A. Richmond
The Role of CDP in the Negative Regulation of CXCL1 Gene Expression
J. Biol. Chem., July 6, 2001; 276(28): 26122 - 26131.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.